SCHEMBL6519362

SCHEMBL6519362

CCc1ccc(CN2CC(Oc3ccc(-c4ccc(C(N)=O)c(F)c4)nc3)C2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 3/20 0.45
PARP1 P09874 1/20 0.42
GRM2 Q14416 2/20 0.40
S1PR1 P21453 1/20 0.40
S1PR5 Q9H228 1/20 0.40
MLNR O43193 4/20 0.39
CYP3A4 P08684 1/20 0.39
KCNH2 Q12809 2/20 0.39
MCHR1 Q99705 1/20 0.39
PARP10 Q53GL7 2/20 0.37
PARP15 Q460N3 1/20 0.37
TP53 P04637 1/20 0.37
ADRB2 P07550 2/20 0.37
MAOB P27338 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
NTRK1 P04629 1/20 0.36
NTRK3 Q16288 1/20 0.36
NTRK2 Q16620 1/20 0.36
MTOR P42345 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6525462 0.93 SMN1; SMN2 (0.43) GPR119PARP1GRM2S1PR1S1PR5
SCHEMBL6521804 0.91 CHRM2 (0.44) GPR119GRM2KCNH2NTRK1NTRK3
SCHEMBL6523552 0.91 GRM2 (0.40) GPR119PARP1GRM2S1PR1MLNR
SCHEMBL6521815 0.91 GPR119 (0.40) GPR119PARP1GRM2S1PR1S1PR5
SCHEMBL3662088 0.90 STAT3 (0.41) GPR119PARP1S1PR1S1PR5ADRB2
SCHEMBL12788257 0.88 GPR119 (0.42) GPR119PARP1GRM2MLNRCYP3A4
SCHEMBL2896254 0.84 GPR119 (0.39) GPR119PARP1GRM2PARP10PARP15
SCHEMBL3654712 0.83 GPR119 (0.40) GPR119PARP1S1PR1ADRB2MAOB
SCHEMBL3659308 0.83 GPR119 (0.40) GPR119PARP1GRM2S1PR1MLNR
SCHEMBL3658326 0.82 LIPG (0.45) S1PR1S1PR5ADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110059942-A1 Azetidinyl G-Protein Coupled Receptor Agonists PROSIDION LIMITED (GB) 2011-03-10 US disclosed
US-20110059942-A1 Azetidinyl G-Protein Coupled Receptor Agonists PROSIDION LIMITED (GB) 2011-03-10 US disclosed
US-20110059942-A1 Azetidinyl G-Protein Coupled Receptor Agonists PROSIDION LIMITED (GB) 2011-03-10 US disclosed
WO-2009050522-A1 AZETIDINYL G-PROTEIN COUPLED RECEPTOR AGONISTS PROSIDION LIMITED (GB) 2009-04-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110059942-A1 Azetidinyl G-Protein Coupled Receptor Agonists GPR119, GIPR, GPR39 GPR119 1/4885PARP1 4791/4885GRM2 236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.